montelukast FDA Link

a leukotriene D4 receptor antagonist

Also Known As:

Singulair; 1- ((((1R)- 1- (3- ((E)- 2- (7- chloro- 2- quinolinyl)ethenyl)phenyl)- 3- (2- (1- hydroxy- 1- methylethyl)phenyl)propyl)thio)methyl)- cyclopropaneacetic acid; MK 0476; MK-0476; montelukast sodium; sodium 1- (((1- (3- (2- (7- chloro- 2- quinolinyl)ethenyl)phenyl)- 3- (2- (1- hydroxy- 1- methylethyl)phenyl)propyl)thio)methyl)cyclopropylacetate

Pharmalogical Action Categories:

D018927 - Anti-Asthmatic Agents
D020024 - Leukotriene Antagonists
D065694 - Cytochrome P-450 CYP1A2 Inducers

Organic Chemicals: 140
- Hydrocarbons: 1726
  - Cyclic Hydrocarbons: 96
    - Alicyclic Hydrocarbons: 1
      - Cycloparaffins: 6
        Cyclopropanes: 9
        montelukast: 1696
- Carboxylic Acids: 986
  - Acyclic Acids
    - Acetates: 5093
      - montelukast: 1696
- Sulfur Compounds: 283
  - Sulfides: 1092
    - montelukast: 1696
Lipids: 118169
- Fatty Acids: 28212
  - Volatile Fatty Acids: 3325
    - Acetates: 5093
      - montelukast: 1696
Heterocyclic Compounds: 207
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinolines: 148
      - montelukast: 1696
Inorganic Chemicals: 9
- Electrolytes: 16464
  - Ions: 8156
    - Anions: 3558
      - Sulfides: 1092
        montelukast: 1696
- Sulfur Compounds: 283
  - Hydrogen Sulfide: 2855
    - Sulfides: 1092
      - montelukast: 1696

Jai Prashar Selected Research

Jai Prashar Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure